Results 21 to 30 of about 1,399,448 (251)

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin [PDF]

, 2010
Harald Vonkeman, Inger Meek, Mart van de LaarDepartment of Rheumatology and Clinical Immunology, Arthritis Centre Twente, Medisch Spectrum Twente and University of Twente, Enschede, The NetherlandsAbstract: Low-dose aspirin is widely used in the primary ...
Vonkeman, Harald, Inger Meek, Harald Vonkeman, Mart van de Laar, Meek, Inger, van de Laar, Mart   +5 more
core   +1 more source

Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.

PLoS ONE, 2019
Stroke patients are at high risk of developing pneumonia, which is major cause of post-stroke mortality. Proton pump inhibitors and H2 receptor antagonists are anti-ulcer drugs, which may predispose to the development of pneumonia by suppression of the ...
Tae-Jin Song, Jinkwon Kim
doaj   +1 more source

PROTON PUMP INHIBITORS AS AN ADDITIONAL RISK TO DEVELOPMENT OF MRONJ: HISTORICAL PROSPECTIVE STUDY [PDF]

, 2022
PROTON PUMP INHIBITORS AS AN ADDITIONAL RISK TO DEVELOPMENT OF ...
Nespoli Stefania, Riviera Marco, Daldos Matteo, Rampinelli Michele, Trentini Carlo, Salgarello Stefano, Floriani Mattia, Audino Elisabetta, Di Salvo Giulio, Ferranti Susanna, Cavaggioni Ambra, Zanin R., Bernardi S., Brugnera C., Michelon F., Bevilacqua L., Maglione M., Rinaldi F., Petrelli P., Fioretti Andrea, Bardhi E., Treccani Francesca, Varvara G., Andrisani M., Angerame D., De Cicco C. A., Piattelli M., Dalessandri Domenico, AA VV AA VV, Cioffi Chiara, Lenhardt M., Orlandi Simone, Bertolotto M., Schmelzeisen R.   +33 more
core   +1 more source

The impact of drug-drug interactions between proton pump inhibitors and metformin: A systematic review of clinical evidence [PDF]

Pharmacia
Metformin, a substrate of the organic cation transporters, is commonly co-prescribed with proton pump inhibitors, which inhibits these transporters. However, the clinical significance of this potential drug-drug interaction remains unclear.
Ria Andani Antong, Ikhwan Yuda Kusuma, Marianti A. Manggau, Muh Akbar Bahar   +3 more
doaj   +3 more sources

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors

eJHaem, 2020
Background Iron deficiency anemia without evidence for blood loss can present a diagnostic challenge. Proton pump inhibitors have been associated with iron deficiency anemia for many years, yet the relationship between the two until recently was not ...
Michael Boxer
doaj   +1 more source

Proton-pump inhibitors used in the out-patient clinic.

, 2018
Proton-pump inhibitors used in the out-patient clinic.
Joonbyung Park (5746610), Suyeon Park (2818120), Jin Seok Jeon (4390105), HyunJin Noh (5746613), Soon Hyo Kwon (4390111), Haekyung Lee (2308426), Song Hee Oh (5746607), Hee Jeong Lee (5746604), Dong Cheol Han (4390108)   +8 more
core   +1 more source

Proton pump inhibitor-induced Sweet’s syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer

Dermatology Practical & Conceptual, 2015
Background: Sweet’s syndrome, also referred to as acute febrile neutrophilic dermatosis, can either occur as an idiopathic disorder or associated with another condition, including cancer, or induced by exposure to a drug.
Philip R. Cohen
doaj   +1 more source

The choice of proton pump inhibitor from the standpoint of efficacy and safety in a particular patient

Лечащий Врач, 2021
Proton pump inhibitors are a diverse class of drugs with unique acid suppression properties. The aim of the work was to present the therapeutic benefits of rabeprazole and pantoprazole in clinical practice.
E. A. Lyalukova, Yu. V. Tereschenko, E. N. Chernysheva, A. V. Lyalukov   +3 more
doaj   +1 more source

Proton pump inhibitors overuse - consequences among patients

Journal of Education, Health and Sport, 2019
Introduction Omeprazole was first proton pump inhibitor (PPI) approved for use by patients. Thirty years have passed since then. Due to their effectiveness, low price and safety proton pump inhibitors have become one of the most frequently prescribed ...
Patrycja Kmiotek, Andrzej Materniak, Barbara Skrzydło-Radomańska   +2 more
doaj   +3 more sources

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors

Laryngoscope Investigative Otolaryngology
Objective Calcium homeostasis is regulated by the effects of parathyroid hormone (PTH) and vitamin D on the bones, GI tract, and kidneys. Post‐thyroidectomy hypoparathyroidism and resultant hypocalcemia are common complications associated with prolonged ...
Maxwell Rossip, F. Jeffrey Lorenz, Neerav Goyal, David Goldenberg   +3 more
doaj   +1 more source